Simtuzumab (LOXL2) - Research Grade Biosimilar
Product Specifications
Background
Simtuzumab has been used in trials studying the treatment and basic science of Myelofibrosis, Pancreatic Cancer, Colorectal Cancer, and Idiopathic Pulmonary Fibrosis.
Immunogen
Humanized / LOXL2 [Homo sapiens]
Clonality
Recombinant Monoclonal
Conjugation
Unconjugated
Type
Primary Antibodies, Biosimilars
Source
CHO cells
Field of Research
Neuroscience
Purification
>95%
Concentration
Batch dependent
Buffer
PBS buffer pH7.5
Modification
None
Shipping Conditions
Blue Ice
Storage Conditions
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8 ˚ C for 1-2 weeks. Store at -20 ˚ C for 12 months. Store at -80 ˚ C for long term storage.
Fragment
IgG4-kappa
NCBI Organism
Homo sapiens
Other Product Names
AB0024, GS-6624
More Discoveries
Explore Other Products
Browse additional items from our catalog
MF-0131529-01 5 µg
DLL3 Protein (Primary Amine Labeling), Human, Recombinant (His), Biotinylated
Sign In for Pricing
View Details 
MF-0131529-02 10 µg
DLL3 Protein (Primary Amine Labeling), Human, Recombinant (His), Biotinylated
Sign In for Pricing
View Details MF-0131529-03 20 µg
DLL3 Protein (Primary Amine Labeling), Human, Recombinant (His), Biotinylated
Sign In for Pricing
View Details MF-0131529-04 50 µg
DLL3 Protein (Primary Amine Labeling), Human, Recombinant (His), Biotinylated
Sign In for Pricing
View Details MF-0131529-05 100 µg
DLL3 Protein (Primary Amine Labeling), Human, Recombinant (His), Biotinylated
Sign In for Pricing
View Details MF-0131529-06 200 µg
DLL3 Protein (Primary Amine Labeling), Human, Recombinant (His), Biotinylated
Sign In for Pricing
View Details